Semi-Annual Statement Of Income And Retained Earnings

Oncolys BioPharma Inc. - Filing #7727011

Concept 2018-01-01 to
2018-03-31
2018-01-01 to
2018-03-31
2018-01-01 to
2018-03-31
2018-01-01 to
2018-03-31
2018-01-01 to
2018-03-31
2017-01-01 to
2017-03-31
2017-01-01 to
2017-03-31
2017-01-01 to
2017-03-31
2017-01-01 to
2017-03-31
2017-01-01 to
2017-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-29,577,000 JPY
-146,400,000 JPY
-156,263,000 JPY
-302,664,000 JPY
-126,686,000 JPY
-121,013,000 JPY
-235,115,000 JPY
-23,299,000 JPY
-114,101,000 JPY
-90,802,000 JPY
Non-operating income
Non-operating income
3,251,000 JPY
1,078,000 JPY
Non-operating expenses
Non-operating expenses
11,026,000 JPY
7,541,000 JPY
Ordinary profit (loss)
-310,439,000 JPY
-241,578,000 JPY
Profit (loss) before income taxes
-310,439,000 JPY
-241,578,000 JPY
Income taxes - current
946,000 JPY
969,000 JPY
Profit (loss)
-311,386,000 JPY
-242,547,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.